INTRODUCTION
Tick-borne encephalitis virus (TBEV), from the family Flaviviridae, is an enveloped, positive-stranded RNA virus. Its genome is translated into one large polyprotein that traverses the endoplasmic reticulum (ER) several times. This polyprotein is co-and post-translationally cleaved by viral and cellular proteases (Lindenbach et al., 2007) . For productive infection, proteolytic processing and assembly of the virus particle must be closely co-ordinated (Amberg & Rice, 1999; Lindenbach et al., 2007) . Structural protein processing leads ultimately to the formation of protein C and the two glycoproteins prM (membrane) and E (envelope) (Lobigs, 1993) . The latter remain anchored in the ER membrane, whereas mature protein C participates in RNA packaging and particle assembly with the newly synthesized mRNA to form the nucleocapsid (Mandl, 2005) . Preformed nucleocapsid has not yet been detected in infected cells. Given that budding of flavivirus membranes is driven by the interactions of prM and E independently of protein C or the assembled nucleocapsid (Lobigs & Lee, 2004) , the co-ordinated cleavage events at the C-prM junction appear to be a key to the efficient incorporation of nucleocapsid during flavivirus assembly.
Cleavage by the viral protease NS2B3 (NS2B/3 pro ) in the C-terminal region of protein C is a prerequisite for the subsequent signallase cleavage inside the lumen of the ER that generates the N terminus of prM (Amberg & Rice, 1999) . The signallase cleavage site of prM is thought to be maintained in a predominantly cryptic conformation until cleavage of C by NS2B/3 pro . This prevents cotranslational signallase cleavage of prM and should result in transient 3These authors contributed equally to this work. expression of a C-prM intermediate at the putative flavivirus assembly site on the ER membrane until cytosolic processing by the viral protease has taken place (Lobigs & Lee, 2004) . The importance of the concerted progression of the cleavage events at the C-prM junction has been documented in yellow fever virus, Murray Valley encephalitis virus and TBEV. Inhibition of protein C cleavage or disturbance of the cleavage order interfered with or even abrogated viral growth and infectivity (Amberg & Rice, 1999; Chappell et al., 2005; Lee et al., 2000; Lobigs & Lee, 2004; Schrauf et al., 2008; Stocks & Lobigs, 1998) .
The exact position of the TBEV NS2B/3 pro protein C cleavage site and the cleavage sequence itself are highly flexible (Schrauf et al., 2008) . Furthermore, this NS2B/3 pro cleavage site can be replaced by the FMDV (foot-andmouth disease virus) 2A protein sequence in both TBEV and West Nile Virus (WNV) (Schrauf et al., 2009) . This 2A sequence enables the release of mature protein C from the polyprotein in the absence of proteolysis through a 'StopGo' mechanism that promotes reinitiation on the translating ribosome (Atkins et al., 2007) . The release of protein C thus occurs co-translationally and prematurely compared with that in the wild-type. In addition, the mechanism of action of FMDV 2A results in a protein C with a 19 aa C-terminal extension. Examination of the resulting TBEV mutants showed an altered buoyant density and a reduction of early RNA synthesis upon viral infection but not with electroporation of naked RNA, suggesting previously unrecognized roles of protein C in uncoating and/or early RNA replication (Schrauf et al., 2009 ).
Here, we further characterize the function(s) of protein C by making the C/prM cleavage dependent on the synthesis of a heterologous protease, the FMDV 3C pro (Curry et al., 2007) .
RESULTS
Constructing a system allowing protein C cleavage to be performed by a heterologous protease TBEV variants in which the NS2B/3 pro cleavage site at the C terminus of the protein C had been replaced by the 20 aa FMDV 2A protein still produce infectious virions (Schrauf et al., 2009) . Generation of the mature protein C is accomplished by a 'StopGo' mechanism in which a PGP motif located at the C-terminal end of the FMDV 2A protein causes the ribosomes to skip peptide bond formation (Donnelly et al., 2001) .
Mutants lacking the PGP motif cannot perform the StopGo process, preventing separation of protein C from prM and consequently virion production, even in the presence of viral RNA and protein synthesis. Could the expression of the 3C pro of FMDV rescue mutants lacking PGP by cleaving between the C terminus of protein C and the N terminus the FMDV 2A sequence? To address this question, we took the mutant TBEV 2AD3 (Fig. 1a) (Schrauf et al., 2009 ) lacking the PGP motif at the C terminus of 2A. At the N terminus of the 2A sequence, there is a suboptimal cleavage motif for the FMDV 3C pro , RGKQ*TLN (the asterisk indicates the cleavage site). To improve this cleavage site, we inserted the amino acids PV and QV between the glycine and lysine residues, optimizing the P4 and P3 positions (Fig. 1a) . It has been previously demonstrated (Birtley et al., 2005) that the P4 position is also important for 3C pro cleavage. To further enhance the system, we also introduced the mutation E122G into protein E (PV-2AD3-H and QV-2AD3-H, Fig. 1a ). This substitution enables the virus to use heparan sulphate to bind to BHK-21 cells, thus increasing the specific infectivity and binding affinity by up to 10-fold (Kroschewski et al., 2003) .
To express FMDV 3C
pro , we used a TBEV replicon lacking the coding region for the structural proteins prM and E (Fig. 1b) . This replicon cannot produce infectious viral particles on its own but can replicate RNA and express a heterologous protein from a second ORF at the 39 end (Gehrke et al., 2005) . We placed the FMDV 3C pro coding sequence after the EMCV IRES element (DME-I-3C, Fig.  1b) . We also prepared a replicon expressing an inactive 3C pro (DME-I-3Ci, Fig. 1b ).
The rationale was that when one of the TBEV 2AD3 mutants and the protease-encoding TBEV replicon are present within the same cell, the FMDV 3C pro expressed from the replicon should recognize its cleavage motif at the C-prM junction of the TBEV-2AD3 mutant. This will liberate mature protein C from the signal sequence for prM and allow the signallase to access its cleavage site at the N terminus of prM. These cleavages then enable the generation of all structural proteins leading to the production of single-round infectious particles.
Heterologous expression of the FMDV 3C protease results in virion production
To ensure that replication and protein production still function correctly, we first singly transfected BHK-21 cells with RNAs of DME-I-3C, PV-2AD3-H and QV-2AD3-H. Viral protein expression was analysed after transfection and after the first passage of the supernatant by immunofluorescence (IF) using an antiserum that predominantly recognizes the structural protein E as well as the nonstructural protein NS1. Cells transfected with all RNAs showed viral protein expression (Fig. 2a, upper panel) . Thus, all RNAs were competent for RNA replication, as we have previously shown that only replication-competent mutants generate and process sufficient proteins to be visible by IF (Kofler et al., 2002) . The efficiencies of transfection were approximately 30-40 % for DME-I-3C and 80 % for PV-2AD3-H and QV-2AD3H (Fig. 2a, upper  panel) . As the replicons do not express protein E, it is possible that the efficiency of their transfection is underestimated compared with those of the modified viruses that express both protein E and NS1 that can be recognized by the antiserum used. Twenty-four hours later, phase-contrast microscopy revealed that cells transfected with these showed a strong cytopathic effect (CPE) with the concomitant death of the majority of cells. Passaging of supernatants from the transfected cells did not, however, lead to the production of viable virus (Fig. 2a, lower  panel) .
We then transfected PV-2AD3-H or QV-2AD3-H RNAs together with RNA from the replicon DME-I-3C. After 24 h, cells stained almost 100 % positive for viral protein expression (Fig. 2b, upper panel) , indicating a high electroporation efficiency. As the two replicating constructs both produce the NS1 protein, the antiserum (predominantly recognizing proteins E and NS1) cannot distinguish between them; therefore, we were not able to determine how many cells were double-positive. Nevertheless, IF analysis of singly transfected cells (80-90 % for the TBEV-mutant RNAs and 30-40 % for the DME-I-3C replicon RNA) indicated that at least 20-30 % of the co-transfected cells expressed both constructs. We then used the supernatants of the electroporated cells to infect fresh BHK cells. Using supernatants transfected with the RNAs PV-2AD3-H and DME-I-3C, about 40-50 % of the fresh BHK cells were positive for the production of viral proteins as detected by IF using the antiserum staining for the proteins E and NS1, indicating that virions had been produced by doubly transfected cells (Fig. 2b, lower panel) . In contrast, no positive cells were observed with supernatants from cells transfected with QV-2AD3-H or DME-I-3C RNA (Fig. 2b) , suggesting that the only cleavage site recognized was that with the optimal PV sequence at P3 and P4.
Virion production depends on expression of an active 3C protease
The above results implied that the FMDV 3C pro could rescue the defect in PV-2AD3-H. To provide further evidence and to exclude any involvement of NS2B/3 pro , we constructed a DME replicon containing an inactive 3C pro (DME-I-3Ci; Fig. 1b ) in which the active site cysteine (Cys163) had been mutated to alanine. Cells transfected with DME-I-3Ci RNA alone showed viral protein expression and a CPE ( Fig. 2a and data not shown). However, the supernatant of cells co-transfected with DME-I-3Ci and PV-2AD3-H RNAs did not contain any infectious particles (Fig. 2b) . This strengthens the notion that an active 3C
pro is required for virion production from PV-2AD3-H and that the 3C pro can replace the NS2B/3 pro in protein C cleavage. Protein prM is only formed in the presence of an active 3C protease To assess protein processing at the C-prM junction in cells transfected with full-length TBEV mutants and the DME replicons, we examined protein prM production. All constructs used [i.e. the full-length TBEV mutants (Fig.  1a ) and the DME replicon (Fig. 1b) ] code for protein C; therefore, its analysis provides no information on 3C pro cleavage. However, protein prM is only expressed in cells containing the TBEV mutants when 3C pro cleaves at the cytoplasmic side of the signal sequence for prM, allowing the signallase access to its cleavage site at the N terminus of protein prM. We therefore lysed cells transfected with various RNAs 22 h after transfection and detected the structural proteins E and prM with polyclonal antisera raised against all structural proteins of TBEV and against prM itself, respectively (Fig. 3) . A prominent band corresponding to protein E, indicating viral protein synthesis and processing, was detected in lysates of cells transfected with a full-length TBEV mutant (Fig. 3, upper panel) . In contrast, the band was absent from the lysate transfected with the DME replicon alone. With the anti-prM serum (Fig. 3, lower panel) , a prominent band with a size corresponding to that of protein prM was only detected in lysates of cells transfected with combinations of PV-2AD3-H+DME-I-3C or PV-2AD3+DME-I-3C (Fig. 3 , lower panel, lanes 4 and 7). Cell lysates of the full-length TBEV mutants with the PV-2AD3 motif either alone or in combination with DME-I-3Ci failed to produce any protein prM, indicating no protein processing at the C-prM junction in the absence of an active 3C pro . Furthermore, no protein prM was visible in lysates from cells transfected with RNAs containing the QV-D3-H motif alone or in combination with the 3C pro , indicating that the 3C pro cleavage requires a suitable P4 residue. We did not, however, observe any uncleaved C-2AD3-prM protein in the Western blot with the anti-prM antiserum (Fig. 3, lower panel) . We believe that this is due to the high background at the predicted position (about 35 kDa) as well as a previously observed inability of this antiserum to recognize the C-prM protein. No differences were visible between lysates containing the PV-2AD3 mutant with or without the heparan sulphate mutation; hence, this additional mutation has no impact on processing of the structural proteins (Fig. 3, lanes  4 and 7) .
Supplying the 3C protease in cis also results in TBEV mutant virion production Can 3C
pro also be provided in cis? Accordingly, we constructed full-length TBEV mutants containing the 3C pro cleavage motif P-V-K-Q*T at the C terminus of protein C as well as the coding region for an active or inactive 3C
pro as a second cistron under IRES control (Fig. 4a) . The protein E heparan sulphate mutation was present in all constructs.
RNAs of PV-2AD3-H-I-3C and PV-2AD3-H-I-3Ci were transfected into BHK-21 cells and viral protein expression was examined by IF analysis (Fig. 4b, upper panel) . About 30-40 % of cells transfected with both mutants exhibited a positive IF staining, indicating that both mutants were competent for replication and protein expression. Next, supernatants of the transfected cells were applied to fresh cells and infection of these cells was again monitored by IF (Fig. 4b, lower panel) . RNA from PV-2AD3-H-I-3C produced infectious virions and could be propagated further as indicated by the detection of positive cells after the first passage. No infectious virions were obtained with PV-2AD3-H-I-3Ci containing an inactive 3C pro .
Thus, the presence of the 3C pro cleavage site and the 3C pro sequence on the same genome also allows virion production. However, the efficiency was lower than when 3C pro was supplied in trans.
Passage of 3C protein C cleavage site mutants in the absence of an active 3C protease provokes resuscitating mutations Now, we wished to examine how quickly mutants could arise in the absence of an active 3C pro that would allow the formation of a new NS2B/3 pro protein C cleavage site and thus lead to the production of infectious virions. Accordingly, passaging experiments on BHK-21 cells were performed. First, in vitro-synthesized RNAs of PV-2AD3-H, QV-2AD3-H, PV-2AD3-H-I-3Ci as well as PV-2AD3-H together with RNA of the replicon DME-I-3Ci were electroporated into BHK-21 cells. Then, supernatants from the transfected cells Fig. 3 . Western blot analysis of structural protein processing. Cells transfected with mutant RNAs were lysed 22 h post-transfection, and structural proteins prM and E were detected using polyclonal sera. Positions of marker proteins in kDa are marked were harvested 1 or 2 days post-transfection and transferred onto fresh BHK-21 cells; infection of cells was determined by IF. Cells inoculated with supernatants from day 1 were all negative for viral protein expression (Fig. 5a) . Surprisingly, however, in one of three attempts, 100 % of the cells inoculated with 2 day supernatants derived from PV-2AD3-H transfected cells and about 50 % of cells inoculated with those from QV-2A3D-H and PV-2AD3-H-I-3Ci exhibited a bright IF staining (Fig. 5a) , indicating the production of infectious virions. In contrast, no positive IF was observed with supernatants from cells transfected with the two RNAs PV-2AD3-H+DME-I-3Ci (data not shown).
To identify the responsible mutations, viral RNA was isolated from supernatants 3 days post-infection of the second passage and the entire structural protein-coding region (C-prM-E), as well as the domain comprising the heterologous inactive 3C protease was sequenced. No mutations were found within the protease domain; however, all three mutants had acquired a one nucleotide insertion and a one nucleotide deletion in the structural protein coding region that led to a short change of the reading frame. In PV-2AD3-H, 6 aa within the 2AD3 protein sequence were provided from another reading frame (Fig. 5b) . In contrast, QV-2AD3-H and PV-2AD3-H-I-3Ci, 22 aa in the C-terminal region of protein C and the 2AD3 protein sequence were provided from the same reading frame as in PV-2AD3-H (Fig. 5b) . These alterations not only changed 2AD3 hydrophobicity but also introduced a potential NS2B/3 pro cleavage motif of R-R*C at identical locations in all three revertants.
To ensure that these frame-shifts were responsible for the restoration of infectivity, we introduced the mutations observed in Fig. 5 into the full-length TBEV-2AD3 clone and transfected the RNAs PV-2AD3-mut1, PV-2AD3-mut2 and QV-2AD3-mut into BHK-21 cells. Infectious virions were indeed obtained after passage of the transfection supernatants (data not shown). These passaging experiments also revealed that the virions of PV-2AD3-mut2 and QV-2AD3-mut had a lower infectivity than PV-2AD3-mut1, possibly due to the changes in protein C.
Was the sequence R-R*C being recognized by the TBEV NS2B/3 pro ? Accordingly, we transfected BHK-21 cells with WT-TBEV and mutant RNAs and lysed cells 48 h post-transfection. As expected, WT-TBEV lysates showed prominent bands for the structural proteins E, prM and C (Fig. 6, lane 2) , whereas the mutants showed only prM and E but no C band. Instead a new band was visible, termed C* (Fig. 6 , lane 3, 4 and 5), running slightly slower than the wildtype. The size would correspond to a protein C extended by 14 aa, further indicating that the R-R*C motif is processed by the NS2B/3 pro . Moreover, the ratio of intracellular protein C to the surface proteins prM and E differed in the mutants. Thus, PV-2AD3-mut1 has a C/E ratio similar to that of the WT-TBEV, whereas PV-2AD3-mut2 and QV-2AD3-mut (Fig. 6, lane 4 and 5) show a much higher ratio, suggesting that protein C accumulates in the cytoplasm.
QV-2AD3-mut1 and PV-2AD3-mut are impaired in viral spread
To determine differences in infectious virus progeny production, we examined the ability of the revertants to form foci. WT-TBEV was used as a positive control. As a further control, TBEV-2A was included into the experiments, as its protein C comprises four amino acids more than the second-site revertants and has already been characterized. TBEV-2A foci are 10 times smaller than those produced by the WT-TBEV, and can only be visualized 70 h post-infection, clearly indicating a defect in viral spread (Schrauf et al., 2009) . Interestingly, despite the 14 aa extension of its protein C, foci formed by PV-2AD3-mut1 were only marginally smaller than those formed by the WT-TBEV and could be detected 50 h post-infection (Fig. 7a, bottom) . In contrast, PV-2AD3-mut2 and QV-2A3D-mut formed foci that could be visualized only 70 h post-infection and were considerably smaller than those of the WT-TBEV. However, they were still about three to four times larger than those of TBEV-2A (Fig. 7a, top) .
To quantify the observed differences in infectivity, we compared the growth properties of WT-TBEV, TBEV-2A and the three second site mutants. We performed multistep growth curves in BHK-21 cells at a low m.o.i. of 0.01 as shown in Fig. 7(b) . As previously observed (Schrauf et al., 2009) , TBEV-2A showed a delayed and reduced particle release. In contrast, PV-2AD3-mut1, which forms large foci, produced infectious progeny close to WT level, whereas QV-2AD3-mut1 and PV-2AD3-mut2 showed infectivity titres 1 and 1.5 log units below those of the WT but still between 2.5 and 1.5 log units higher than TBEV-2A (Fig. 7b) .
PV-2AD3-mut1 exhibits a delay in the onset of early RNA replication
The observed defects in infectivity and viral spread of TBEV-2A were proposed to result from an impairment of unpackaging and early RNA synthesis (Schrauf et al., 2009) . To determine the effect of protein C extensions of the revertants on viral replication, we examined early RNA synthesis after infection. As expected, TBEV-2A exhibited a delayed and reduced RNA replication (Fig. 8) . Interestingly, mutant PV-2AD3-mut1 also showed a delay in the onset of RNA replication during the first 6 h postinfection. Nevertheless, after the onset of RNA replication, no further impairment in RNA synthesis was detectable. Indeed, already 9 h post-infection, this mutant produced as many RNA molecules as the WT-TBEV, which is in good accordance with the results shown in Fig. 7 . In contrast, PV-2AD3-mut2 and QV-2AD3-mut produced similar amounts of RNA copies (Fig. 8) . Thus, the reduction of foci size and infectivity of PV-2AD3-mut2 and QV-2AD3-mut does not appear to be the result of an impaired RNA replication.
DISCUSSION
We show here that the production of infectious flaviviral virions can be dependent on protein C cleavage by a heterologous protease, the FMDV 3C pro . Virion production was enabled by providing the enzyme either in cis or in trans from a TBEV replicon. Virion assembly was more efficient when the 3C protease was provided in trans. Most probably, in the cis construction, protein synthesis from the 59 end of the TBEV genome was lowered by the presence of the IRES element in the 39 non-coding region. This has also been observed in bicistronic TBEV mutants in which an IRES element controls the expression of the structural proteins prM and E (Orlinger et al., 2006) .
Cell-based antiviral assays in which the production of infectious virions depends on cleavage by HCV NS3 protease have been reported (Filocamo et al., 1997; Hahm et al., 1996; Lai et al., 2000) . Our system is, however, the first to enable the recovery of a non-infectious virus through a second replicon expressing the required protease. To assess the genetic stability of this system, we investigated how rapidly monocistronic full-length TBEV mutants PV-2AD3-H and QV-2AD3-H would acquire spontaneous mutations during passage on BHK-21 cells in the absence of the 3C pro . Similarly, we also investigated the bicistronic PV-2AD3-H-I-3Ci construction that contains an inactive 3C pro as well as the monocistronic fulllength TBEV mutant PV-2AD3-H together with the TBEV replicon expressing an inactive 3C pro . Multiple amino acid changes at the C-prM junction were observed in the PV-2AD3-H and QV-2AD3-H mutants as well as in PV-2AD3-H-I-3Ci but not in the PV-2AD3-H transfected with the TBEV replicon expressing the inactive 3C
pro . This indicates that the trans-complementation system is more stable than the cis system.
The specific changes in the revertants all resulted from the insertion of one nucleotide and the deletion of a second. Throughout, an NS2B/3 pro cleavage motif R-R*C was introduced at an identical location in the 2AD3 region so that cleavage at this sequence by NS2B/3 pro should give rise to a C-terminal extension of 14 aa in protein C in all three revertants. Furthermore, in PV-2AD3-H, six amino acids within the 2AD3 protein sequence were mutated, whereas in QV-2AD3-H and PV-2AD3-H-3Ci, the insertion and deletion led to the mutation of the same 22 aa, located in both the C-terminal region of protein C and the 2AD3 protein sequence. The new amino acid sequences differed only in the most C-terminal amino acid of the mutated region ( Fig. 5b and c) .
Introduction of the mutations into TBEV-2AD3 confirmed that they restored the production of infectious virus progeny. In addition, protein C of all three mutants showed a slower mobility on SDS-PAGE than the WT (Fig. 6) , strongly suggesting that cleavage was performed by NS2B/ 3 pro at the putative cleavage site.
Differences in the properties of the revertants were evident. PV-2AD3-H-mut1 reached wild-type levels both in infectivity and RNA synthesis and showed only a minor effect on viral spread. However, a delay in the onset of early RNA replication was detectable. The other mutants PV-2AD3-Hmut2 and QV-2AD3-H-mut that bear the almost identical 22 aa change also grew to high titres, just 1 and 1.5 log units lower than WT-TBEV, respectively. Both exhibited a smaller foci size, even though their RNA replication was similar to the WT-TBEV level.
The origin of these differences might be the more hydrophilic character of the protein C extension of all three revertants (compared with that of TBEV-2A), which would favour both the infectivity and early RNA synthesis. This agrees with our previous work on TBEV-2A, indicating that a hydrophobic extension to protein C can interfere with particle formation, viral spread and early RNA replication (Schrauf et al., 2009) . The different behaviour of the revertants in the onset of early RNA replication described here can be also attributed to the Fig. 6 . Analysis of structural-protein processing. Cells transfected with WT or mutant RNAs were lysed 48 h post-transfection, and proteins were detected by immunoblotting using a rabbit polyclonal serum against the TBEV structural proteins. Positions of proteins E, prM, C and C* as well as marker proteins in kDa are marked.
composition of the protein C extension. A comparison of all three revertants and TBEV-2A reveals that the more hydrophobic the extension of protein C, the lower the rate of early RNA synthesis in general and the later the onset of early RNA replication and/or unpackaging in particular.
The amino acid changes of mutants PV-2AD3-H-mut2 and QV-2AD3-H-mut resulted in a more hydrophilic 2AD3 region than in the case of PV-2AD3-H-mut1. Consequently, these two mutants have no impairment in the onset of early RNA synthesis, in marked contrast to the 6 h delay of PV-2AD3-H-mut1. TBEV-2A, however, which possesses an extension of mainly hydrophobic amino acids showed both a delay as well as a reduction in early RNA synthesis. Finally, the observed difference between the revertants and TBEV-2A also suggests that the re-establishment of a NS2B/3 pro cleavage in the C-terminal region of C is advantageous for viral spread.
Despite these beneficial contributions, the more hydrophilic character of the extension did not aid viral spread. PV-2AD3-H-mut2 and QV-2AD3-H-mut, which carry more hydrophilic amino acids in the 2AD3 region than PV-2AD3-H-mut1, formed considerably smaller foci that could be visualized only 3 days post-infection. In contrast, the foci of PV-2AD3-H-mut1 were only marginally smaller than those of the WT. The difference appears to lie in the C-terminal part of protein C, where only PV-2AD3-Hmut2 and QV-2AD3-H-mut have acquired additional mutations. These mutations led to the loss of two basic amino acids in the C-terminal part of protein C. Ma, Dokland and their co-workers (Dokland et al., 2004; Ma et al., 2004) have shown for dengue virus and WNV protein C that protein C occurs as a dimer with the two C-terminal helices forming a broad interface for interaction with RNA. Therefore, the loss of positive charges close to the helix may hinder correct dimer formation and/or RNA binding. Given that the RNA production upon infection was at wild-type levels (Fig. 8) , we can exclude a defect in unpackaging or synthesis of RNA. In contrast, we propose that the accumulation of protein C in the cytoplasm is crucial (Fig. 6) , indicating that the reduced infectivity of PV-2AD3-H-mut2 or QV-2AD3-H-mut is caused by a defect in formation and/or budding of the NC, thus limiting viral spread. In contrast, the protein C of the PV-2AD3-H-mut1 was not affected by the amino acid changes and no accumulation of protein C in the cytoplasm occurred (Fig. 6 ), indicating that budding was undisturbed. Our results highlight therefore a previously undetected role of the C terminus of protein C for budding of the NC and the necessity of positive charges.
METHODS
Plasmids and cells. All TBEV constructs derive from the cDNA of TBEV strain Neudoerfl (GenBank accession no. U27495) (Mandl et al., 1997) . BHK-21 (ATCC CCL10) cells were cultured as described previously (Schrauf et al., 2008) . Oligonucleotides are listed in Supplementary Table S1 (available in JGV Online).
Full-length TBEV mutants. pTNd/59 (Schrauf et al., 2008) and all derivatives of pTNd/59 contain the 59 one-third of the cDNA of TBEV strain Neudoerfl genome. Infectious full-length RNA was generated after in vitro ligation of the 59 cDNA clones with the 39 cDNA clone pTNd/39 (Schrauf et al., 2008) , which contains the 39 two-thirds of the TBEV genome. Plasmid p2AD3/59 was constructed by deleting the PGP motif at the C-terminal end of the FMDV-2A protein sequence of TBEV-2A/59. For plasmid pPV-2AD3/59, the P4 (proline) and the P3 positions (valine) of the 3C pro cleavage site were introduced upstream of lysine 94 of the TBEV protein C using the forward primer P43-F, the reverse primer P43-R and p2A3D/59 as template. Plasmid pPV-2A3D-H/59, containing the P4 and P3 positions of the 3C pro cleavage site as well as the heparan sulphate mutation E122G in protein E, was generated using the forward primer E122G-F, the reverse primer E122G-R and pPV-2A3D/59 as template. Plasmid pQV-2A3D-H/59, containing valine instead of proline at the P4 position of the 3C pro cleavage site, was created using the forward primer PQ-F, the reverse primer PQ-R and pPV-2A3D-H/59 as template.
Plasmid pTNd/c contains a full-length genomic cDNA of the WT TBEV strain Neudoerfl. TBEV-2A contains a functional FMDV-2A sequence that replaces the NS2B/3 cleavage site between protein C and prM. RNA of TBEV mutants with resuscitating mutations in the 2AD3 region was isolated, reverse transcribed and cloned into the pTNd/c cDNA using restriction sites for SalI and SnaBI; the cDNAs have no heparan sulphate mutation.
TBEV replicons. Replicons DME-I-3C and DME-I-3Ci are derivatives of clone DME-eGFP (Gehrke et al., 2005) , expressing the eGFP under the control of the ECMV IRES. The replicon DME-I-3C was created by a three-step PCR strategy. PCR-I was performed using the forward primer AvrII-F, the reverse primer IRES-3C-R and plasmid ME-DeGFP as template. PCR-II amplified the 3C pro with the forward primer IRES-3C-F, the reverse primer 3C-AgeI-R and plasmid pET-3C (provided by Francois Maree, Onderstepoort, South Africa, containing the FMDV 3C sequence of strain O/SAR/19/00) as template. PCR-III was then performed with primers AvrII-F and 3C-AgeI-R using PCR products I and II as template. Then, the AvrIIAgeI fragment of DME-eGFP was replaced by the AvrII and AgeI restricted PCR product III to generate DME-I-3C. Replicon DME-I3Ci, containing a cysteine-to-alanine mutation at position 163 of the 3C protease, was constructed in a similar way as described above, with the primer combinations AvrII-F and C163A-R for PCR-I and C163A-F and AgeI-R for PCR-II. As template, DME-I-3C was used.
Plasmid DME-I-3C was amplified in Escherichia coli Copy Cutter EPI400 (Epicentre) E. coli HB101 was used for all other plasmids.
RNA transcription and transfection. Transcription of RNA in vitro and transfection into BHK-21 cells by electroporation were as described previously (Mandl et al., 1997; Schrauf et al., 2008) .
Detection of viral proteins. Viral protein expression was examined by IF staining and Western blotting. For IF, transfected BHK-21 cells were disseminated into 24-well tissue culture plates containing microscope coverslips and permeabilized by acetone-methanol fixation (1 : 1) 1 day post-transfection. Expression of the structural proteins C, prM and E and the non-structural protein NS1 was visualized by successive incubation with a rabbit polyclonal anti-TBEV serum predominantly recognizing protein E and protein NS1 and fluorescein-isothiocyanate-conjugated anti-rabbit antibody (Jackson Immune Research Laboratory). For passaging experiments, supernatants from transfected BHK-21 cells seeded in 25 cm 2 tissue culture flasks were transferred onto fresh BHK-21 cells 1 day posttransfection and viral protein expression was analysed as described above 1 day post-infection. For the selection of resuscitating mutations, supernatants from transfected cell cultures were applied to fresh cells 2 days post-electroporation and, after a second round of passage, viral protein expression determined.
Formation of the structural proteins prM and E was monitored by immunoblotting (Schrauf et al., 2008) .
Virus stock preparation. To generate virus stocks, BHK-21 cells were electroporated with RNAs of WT-TBEV, TBEV-2A, PV-2AD3-mut1, PV-2AD3-mut2 and QV-2AD3-mut, respectively. Supernatants were harvested 48 h post-electroporation. RNA was isolated from these stocks, followed by reverse transcription. Constructs were confirmed by sequencing. Titre and focus morphology were determined by focus assay.
Multistep growth curves. BHK-21 monolayers grown in six-well plates were infected with stock preparations of respective viruses at a m.o.i of 0.01. Aliquots of supernatants were collected at various time points and infectious particles were quantified by focus assay.
Focus assay. To quantify the production of infectious virus particles, an immunochemical focus assay was employed (Schrauf et al., 2009) .
RNA replication. Intracellular RNA replication after infection was determined as described previously (Schrauf et al., 2009) .
Protein sequence analysis. Hydrophobicity plots were done using the DNASTAR programme PROTEAN (Kyle-doolitle scale, window size 11).
